LSG2G #14 - "We Make the Invisible Visible to Drug the Undruggable"
Meet Philipp Baaske, CEO of Nanotemper in the Livestream from the Podcast Studio and Network with Life Science Leaders in the Afternoon
Dear LSG2G community,
We're excited to invite you to an exclusive live-stream event with
Philipp Baaske, the CEO and founder of NanoTemper, a globally operating biotech company.
Philipp's passion for developing biophysical and AI-based tools to fight diseases like cancer and Alzheimer's is truly inspiring.
In this event, you will learn about NanoTemper's biophysical tools and how they enable their customers to develop therapies for "undruggable" diseases.
You'll also hear about Philipp's personal beliefs in standing for democracy and equality and how he is inspiring people to overcome the limits they set for themselves.
This live stream is your opportunity to learn from a successful biotech entrepreneur and discover how you can be part of creating a world where every disease is treatable. Don't miss out on this chance to think big and make a global impact. Register now to secure your spot at the forefront of the biotech industry.
Exclusive invitation for supporting members of the LSG2G community (9,000+ investors and entrepreneurs, 70,000+ with media partners).
Join the live stream and ask questions to Philipp Baaske:
Do you want to enjoy the content but can’t join the live stream? We’ve got you covered. You can watch the conversation on our Linkedin Profile anytime you want.
Or get the timestamped episode on our Youtube and Podcast Channels a few days after the recording. So that you can select the parts that benefit your work the most.
But that's not all!
After the live stream,
we're hosting a networking get2gether at Marx Restauration on March 16 from 3 pm to 5 pm.
This is your chance to connect with like-minded individuals who share your passion for innovative biotech solutions, including Philipp and other industry leaders.
You'll have the opportunity to
Share your thoughts and ideas on making a world where every disease is treatable a reality, and learn more about NanoTemper's latest innovations.
Don't miss this exclusive opportunity to connect with one of the most successful European life science companies and take the first step towards creating a better future for all.
Register now and secure your spot at the networking get2gether.
Together, we can make the invisible visible and drug the undruggable. (Philipp Baaske)
Let's create a world where every disease is treatable.
Upcoming Conversations and Events:
Check out the Q1 highlight on March 16:
From Blue Collar to Biotech: The Incredible Journey of NanoTemper CEO Philipp Baaske and His Search for Investment Amidst Financial Crisis."
The CEO of Nanotemper, Dr. Philipp Baaske, will join us in Vienna in our Recording Studio to discuss his journey as an entrepreneur.
What challenges did he have to overcome?
Why did he decide to bootstrap his company?
How did he find customers and a business angel to get off the ground?
Join us as we delve into Philipp Baaske's inspiring story of perseverance and determination in founding NanoTemper and the invaluable lessons he learned from his angel investor Volker Hofmann on the road to success.
Tune in to hear about the power of belief in your ideas, the importance of support from family and friends, and the impact an angel investor can have on a startup.
Timetable for March 16, 2023
11:30 am CET - Philipp Baaske - Livestream on Linkedin and Zoom Webinar directly from the Podcasting Studio
3 pm CET - LSG2G Networking Get2gether: Meet Philipp Baaske.
March 24, 2023 - 3 pm CET - Colin McCann - Global Affairs Manager at International Vaccine Institute (IVI)
Meet us at the AngloNordic Conference on April 20, 2023
We are looking for speakers. Do you know interesting experts in these areas?
Longevity, preventive medicine, and well-being;
pharma and health tech;
and entrepreneurship and investing.
Send a mail to email@example.com
Top PrivateYC Companies - 2023 Since 2005, YC has funded over 4,000 startups, including many that have become household names. Discover the top private, public, and exited companies that are part of the YC community here. Read more…
Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trials For the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials.
Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug "significantly reduces" viral load and inflammation in the lungs. Read more …
Nvidia predicts AI models one million times more powerful than ChatGPT within 10 years A million here, times a million there. Pretty soon you're talking about big numbers. So Nvidia claims for its AI accelerating hardware in terms of the performance boost it has delivered over the last decade and will deliver again over the next 10 years. Read more…
2 Podcasts from this week:
#107: Jack Scannell - Uncovering Drug Development Efficiency Secrets: The Science Behind Pharmaceutical Research
The Health Expert: The One Food (WE ALL EAT) That's Killing Us Slowly: Max Lugavere | E223
1 Youtube Takeaway from this week
Books I am reading this week
At this Silicon Valley startup, murder is a feature, not a bug…
SüprDüpr is the hottest startup in Silicon Valley until one of the company’s physicists disappears and hacker Ted Hara sets out to find his missing friend.
Led by a glamorous young scientist and funded by billionaire crypto investors, SüprDüpr promises to revolutionize transportation. But as Ted investigates the secretive company, nothing is what it seems.
Are the millions the company is spending building a homeless shelter truly corporate philanthropy? Or is the company a complex real estate scam? As the homeless residents of San Jose begin disappearing, too, it appears something far more sinister is happening downtown. But why was his friend searching for a pair of elephants before he disappeared?
Days away from the technology unveiling that will confer unimaginable riches on the company’s investors, Ted becomes trapped in a web of corruption protecting its founder. While avoiding the police, he has to find out why people are disappearing before it’s too late.
A crazy ride through the high-tech world of Silicon Valley, To Kill a Unicorn shows how far startup founders are willing to go to build their unicorns.
To Kill a Unicorn
Best Quote from this week
“Success is to wake up each morning and consciously decide that today will be the best day of your life.”
Offers for the LSG2G Community:
Do you want to use the podcast for your communication and marketing goals?
Let's schedule a Zoom Call:
Do you want help with communication, business development, or financing?
Get in touch with CS Life Science Invest:
Support the Show:
If you enjoy the LSG2G Podcast Beginners Mind, you can help support the show by doing the following:
Become a Subscriber and get access to the recordings, tickets to our online and real-life events, or help with your contribution to developing the community further
Subscribe on Apple | Spotify | YouTube | and leave a comment and rating
Share the show and episodes with your friends and family with this Link
If you are interested in sponsoring the show, please feel free to drop me an email to discuss options.
These companies make the community, this newsletter, and the LSG2G Podcast possible, so go check them out and thank them for their support!
You are receiving the LSG2G Letter because you either signed up or attended one of the events organized by LSG2G. Feel free to unsubscribe if you aren’t finding this valuable.
Nothing in this email is intended to serve as financial advice. Do your own research.